TORONTO, April 14 /CNW/ - Lorus Therapeutics Inc. (Lorus), a
biopharmaceutical company specializing in the research and development of
pharmaceutical products and technologies for the management of cancer, today
reported financial results for the three and nine months ended February 29,
2008. Unless specified otherwise, all amounts are in Canadian dollars.
